Tert-butylhydroquinone protects the spinal cord against inflammatory response produced by spinal cord injury

Annals of Clinical and Laboratory Science

Volumn 44, Issue 2, 2014, Pages 151-157

  Jin, Wei ^a   Ni, Hongbin ^a   Hou, Xiaoshan ^a   Ming, Xing ^a   Wang, Jing ^a   Yuan, Baoyu ^a   Zhu, Tiansheng ^a   Jiang, Jian ^a   Wang, Handong ^a   Liang, Weibang ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Inflammatory response; Nrf2; Spinal cord injury; tBHQ

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; 2-TERT-BUTYLHYDROQUINONE; AUTACOID; CYTOKINE; DNA; HYDROQUINONE DERIVATIVE; NEUROPROTECTIVE AGENT; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BLOOD VESSEL CLIP; CONTROLLED STUDY; CYTOKINE PRODUCTION; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HINDLIMB; INFLAMMATION; LAMINECTOMY; LOCOMOTION; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD INJURY; ANIMAL; BLOOD BRAIN BARRIER; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT; SURGERY;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; CYTOKINES; DISEASE MODELS, ANIMAL; DNA; EDEMA; HINDLIMB; HYDROQUINONES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; NF-KAPPA B; PROTEIN BINDING; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84899749141     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Choo AM, Liu J, Dvorak M, TetzlaffW, Oxland TR. Secondary pathology following contusion, dislocation, and distraction spinal cord injuries. Exp Neurol 2008; 212: 490-506.
2. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008; 209: 378-388.
3. Trivedi A, Olivas AD, Noble-Haeusslein LJ. Inflammation and Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes. Clin Neurosci Res 2006; 6: 283-292.
4. Rafati DS, Geissler K, Johnson K, Unabia G, Hulsebosch C Nesic-Taylor O, Perez-Polo JR. Nuclear factor-kappaB decoy amelioration of spinal cord injury-induced inflammation and behavior outcomes. J Neurosci Res 2008; 86: 566-580.
5. Chen X, Zhou C, Guo J, Sun K, Zhao N, Yang J, Sun Y, Liu X Hibi T, Liu Z, Han J. Effects of dihydroxylphenyl lactic acid on inflammatory responses in spinal cord injury. Brain Res 2011;1372:160-168.
6. Wang X, de Rivero Vaccari JP, Wang H, Diaz P, German R Marcillo AE, Keane RW. Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury. J Neurotrauma 2012;29:936-945.
7. Mao L, Wang H, Wang X, Liao H, Zhao X. Transcription factor Nrf2 protects the spinal cord from inflammation produced by spinal cord injury. J Surg Res 2011; 170:e105-115.
8. Koh K, Cha Y, Kim S, Kim J. tBHQ inhibits LPS-induced microglial activation via Nrf2-mediated suppression of p38 phosphorylation. Biochem Biophys Res Commun 2009;380:449.
9. Nishizono S, Hayami T, Ikeda I, Imaizumi K. Protection against the diabetogenic effect of feeding tert-butylhydroquinone to rats prior to the administration of streptozotocin. Biosci Biotechnol Biochem 2000;64:1153.
10. Keum YS, Han YH, Liew C, Kim JH, Xu C, Yuan X Shakarjian MP, Chong S, Kong AN. Induction of heme oxygenase-1 (HO-1) and NAD[P]H: quinone oxidoreductase 1 (NQO1) by a phenolic antioxidant, butylated hydroxyanisole (BHA) and its metabolite, tert-butylhydroquinone (tBHQ) in primary-cultured human and rat hepatocytes. Pharm Res 2006;23:2586.
11. Nakamura Y, Kumagai T, Yoshida C, Naito Y, Miyamoto M Ohigashi H, Osawa T, Uchida K. Pivotal role of electrophilicity in glutathione S-transferase induction by tert-butylhydroquinone. Biochemistry 2003;42:4300.
12. Lamb JG, Franklin MR. Early events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: comparison with oltipraz, tert-butyl-4-hydroxyanisole and tert-butylhydroquinone. Drug Metab Dispos 2000;28:1018.
13. Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 2008;28:13574.
14. Li J, Johnson D, Calkins M, Wright L, Svendsen C, Johnson J. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol Sci 2005;83:313.
15. Nouhi F, Tusi SK, Abdi A, Khodagholi F. Dietary supplementation with tBHQ, an Nrf2 stabilizer molecule, confers neuroprotection against apoptosis in amyloid β-injected rat. Neurochem Res 2011; 36: 870-878.
16. Jin W, Kong J, Wang HD, Wu J, Lu TY, Jiang J, Liang WB. Protective effect of tert-butylhydroquinone on cerebral inflammatory response following traumatic brain injury in mice. Injury 2011; 42: 714-718.
17. Liang WB, Han QQ, Jin W, Xiao ZF, Huang JC, Ni HB, Chen B, Kong J, Wu J, Dai JW. The promotion of neurological recovery in the rat spinal cord crushed injury model by collagenbinding BDNF. Biomaterials 2010; 31: 8634-8641.
18. Jin W, Wang HD, Yan W, Zhu L, Hu ZG, Ding YS, Tang K. Role of Nrf2 in protection against traumatic brain injury in mice. J Neurotrauma 2009;26:131-138.
19. Jin W, Wang HD, Yan W, Xu LZ, Wang XL, Zhao XN, Yang XH, Chen G, Ji Y. Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm 2008;2008:725174.
20. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997;236:313-322.
21. Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10:549-557.
22. Osburn WO, Wakabayashi N, Misra V, Nilles T, Biswal S Trush MA, Kensler TW. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Biochem Biophys 2006;454:7-15.
23. Jain AK, Bloom DA, Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem 2005;280:29158-29168.
24. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 2003;278:12029-12038.
25. Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci U S A 2005;102:244-249.
26. No authors listed. Evaluation of certain food additives and contaminants. Forty-ninth report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organ Tech Rep Ser 1999;884:1-96.
27. Kraft AD, Johnson DA, Johnson JA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 2004;24:1101-1112.
28. Yan D, Dong J, Sulik KK, Chen SY. Induction of the Nrf2-driven antioxidant response by tert-butylhydroquinone prevents ethanol-induced apoptosis in cranial neural crest cells. Biochem Pharmacol 2010;80:144-149.
29. Johnson DA, Andrews GK, Xu W, Johnson JA. Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice. J Neurochem 2002;81:1233-41.
30. Shih AY, Li P, Murphy TH. A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci 2005;25:10321-35.
31. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD Yezierski RP. Traumatic spinal cord injury induces nuclear factor- kappaB activation. J Neurosci 1998; 18: 3251-3260.
32. Chen F, Castranova V, Shi X, Dwmers LM. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999;45:7-17.
33. Moon DO, Kim MO, Kang SH, Choi YH, Kim GY. Sulforaphane suppresses TNF-alpha-mediated activation of NF-kappaB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3. Cancer Lett 2009;274: 132-142.
34. Sharma HS, Badgaiyan RD, Alm P, Mohanty S, Wiklund L. Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury-induced pathophysiology and motor functions: An experimental study in the rat. Ann N Y Acad Sci 2005;1053:422-434.
35. Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 2006; 116: 984-995.